The preclinical model consists of eight breast cancer cell lines with increasing levels HER-2 expression and/or amplification: MDA-MB-436, SUM190, 9,[11][12][13][14][15][16] Table S2 ). In total, 45/116 (38.8%) samples contained ≥5 CTC/7,5 ml blood. For the inter-observer concordance study, 17 international pathologist and scientists scored 2000 CellSearch® HER-2-FITC thumbnail images of CTCs acquired from MBC patients who were enrolled, after written informed consent, in several CTC studies at the Erasmus MC (Rotterdam, The Netherlands). For this part we included all single, fully visible CTC images of selected patients (known to be CTC-HER-2 positive or negative) regardless of image quality.
HER-2 IF scoring methods
Image-based HER-2 fluorescent intensities were analyzed using three methodologies.
First, a semi-quantitative scale, which classifies the cells into 0, 1+, 2+, and 3+ was employed, as previously described [9] . 0 and 1+ cells are considered negative. They have a pixelated cell staining with a grey and pixelated background. While 2+ and 3+ cells have sharp edge and fluent cell staining with a dark to completely black background respectively. Using an online survey platform, CellTracks Analyzer II® CTC images (n=2000) were reviewed by 17 international scientists and pathologists, who were trained to perform the visual semi-quantitative HER-2 scoring. The obtained scores were benchmarked against the automated scoring results by ACCEPT [8] .
Secondly, ACCEPT was used to automatically analyze the raw TIFF images from the CellTracks Analyzer II® (Menarini Silicon Biosystems Inc.) [8] . CTC identification, and classification of HER-2 intensity levels (negative, medium, and high) was performed with gating and HER-2-FITC cutoff settings as previously described [8, 17] . It generates multiple parameters on shape and fluorescent intensities per individual cell. Cut-offs were set for CTCs (CD45-APC mean intensity ≤ 5, DAPI mean intensity >45, CK-PE mean intensity >60, CK-PE size 16-400, CK-PE overlay with DAPI >0.2) and leukocytes (CK-PE ≤ 5, DAPI mean intensity >45, CD45-APC mean intensity >5, CD45-APC size 16-400, CD45-APC overlay with DAPI >0.2).
HER-2 scoring is divided in negative (HER-2 mean intensity is 0), medium (HER-2 mean intensity is ≤100), and high (HER-2 mean intensity is >100).
Thirdly, CellSearch®-enriched CTC samples were transferred to the DEPArray™ system (Menarini Silicon Biosystems Inc.), as described previously [18] . Briefly, the loaded sample is automatically injected into the microchamber of a cartridge where single cells are trapped in one of 16,000 electrical cages. IF images of the entire surface area are taken and cells are automatically detected by the system, synthesis and ERBB2 pre-amplification was performed on 25% of the isolated RNA, using the RevertAid H Minus First Strand cDNA and TaqMan PreAmp amplification kit, respectively (Thermo Fisher Scientific #K1632 and #4488593, Merelbeke, Belgium), in a GeneAmp® PCR System 9700 (Life technologies). Pre-amplified cDNA was diluted 15x with 1xTE-buffer, after which qRT-PCR was performed to quantitate ERBB2 transcripts. Additionally, 3 housekeeping genes (SDHA, HMBS and HPRT1) were used to control for sample loading and RNA integrity. Epithelial (EPCAM, KRT19) and leukocyte (PTPRC coding for CD45) markers were used to control for presence of epithelial and leukocyte content. PCR reactions (40 cycles) were performed using TaqMan Gene Expression Assays with Universal PCR Master Mix No AmpErase UNG on a 7900HT Fast Real-time PCR System (all Applied Biosystems). A calibrator (positive control) sample was used in each run to assess inter-run variability.
Negative controls included a NTC and -RT sample. Only samples with a Cq value of <35 for each of the was normalized to the epithelial signal within that sample (dCq). All samples were further normalized to the calibrator (ddCq). RGE was calculated as 2^-ddCq.
HER-2 FISH on CTC A FISH protocol was established using the preclinical cell line model. CellSearch® enriched cells were spinned on a Superfrost Plus slide (Fisherbrand) using a Slide carrier with a 1ml One-Funnel Cytochamber (cat. 1662 and 1663 resp., Hettich, The Hague, The Netherlands). Cells were fixed on the slides in acetone at 4˚C for 5 minutes. FISH on slides was performed using the DAKO IQFISH kit (Agilent, Diegem, Belgium), including a pretreatment step, denaturation and hybridization, a stringent wash, mounting, and reading. A detailed prescription of the protocol is written in the table below. Before and after FISH, slides were scanned on the BioView® with CTC protocol (BioView®, Israel), in order to detect and map the tumor cells in the leukocyte background before the FISH protocol was applied.
Amplification status was scored by the algorithm included in the BioView® software. Furthermore, four patient samples were subjected to HER-2 FISH analysis on BioView®.
